Designing a Global Market Access Strategy Bui...

Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access rou ...  Show more

Send us Fan MailWhat does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams responding?In this Petauri Evidence NHS Whispers session, we put your questions to Yousaf Ahmad (Chief Pharmacist and Dir ...  Show more

The unprecedented challenges we have experienced in planning and delivering all aspects of health and care services during the COVID-19 pandemic have acted as a catalyst for testing innovative, outcome focused approaches. This has brought a new focus to how we deliver safe, perso ...  Show more

CIPD’s latest health and wellbeing at work report revealed that sickness absence is at a ten-year high and that wellbeing support for individuals at different life stages can be patchy. So, how can organisations offer sophisticated and nuanced wellbeing support without truly unde ...  Show more

Welcome to the Strategy& Insider Podcast. In our first season, we will discuss some of the most fundamental questions about the Future of Health. Our guests are experts across all sectors of the healthcare industry including pharma executives, leading academics and medical physic ...  Show more

Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas. In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatme ...  Show more